Dr al-Tamimi addressing the symposium yesterday. The evolution, advances, clinical potential and future expectations of Positron Emission Tomography magnetic resonance imaging (PET MRI) as well as hybrid imaging were some of the high points of the 'Second Qatar PET and Molecular Nuclear Medicine Symposium (QPET-II), hosted by Hamad Medical Corporation (HMC) yesterday. Physicians, specialty nurses, physicists and other healthcare professionals from across the country gathered to discuss and exchange ideas on advances in PET and Nuclear Medicine. The event featured presentations and open discussions on PET-CT (a combination of PET and computed tomography) application in oncology, breast carcinoma and gynaecological malignancies, head and neck cancer, lung cancer, liver tumours, lymphoma and neuron-endocrine tumours. Several workshops were conducted on the principles of nuclear medicine and also on radiation protection for staff and family members. "This symposium is highlighting the advances and clinical updates in PET and nuclear medicine. Hosting the event is part of our strategy to spread knowledge on cutting-edge diagnostic and treatment monitoring technologies that will aid healthcare professionals in providing optimal patient care," said Dr Nawal al-Tamimi, QPET-II chairperson and HMC radiology department nuclear medicine consultant. The symposium provided an opportunity for sharing experiences and knowledge, and also allowed participants to learn from internationally recognised experts in the field. Speakers included UK-based Imperial College Healthcare NHS Trust professor and Nuclear Medicine Service chief Adil al-Nahhas; Australia'sAustin Health in Nuclear Medicine physician Dr Sze Ting Lee; Austin Health Clinical PET programme head Dr Salvatore Berlangieri; King Faisal Specialist Hospital and Research Centre's consultant molecular imaging radiologist Dr Ahmad Ibrahim Almuhaideb; and HMC's radiology department senior consultant Prof Dr Ahmed Khairy. PET, also known as PET imaging or a PET scan, is a non-invasive, painless molecular imaging technology that allows physicians to determine how organs and tissues inside the body are functioning on a molecular and cellular level. PET is a powerful tool for diagnosing and determining the stages of many types of cancer, as well as other ailments such as brain disorders and heart problems. HMC's state-of-the-art PET-CT Centre for Diagnosis and Research is one of the most technologically advanced in the region, offering complete patient care ranging from diagnosis to assessment of treatment response for cancer, cardiology and neurology patients. "We hope that this symposium will benefit the daily practice not only of radiologists and nuclear medicine physicians but also other healthcare professionals from different specialties. There will also be an interactive quiz session with a chance for 10 participants to win prizes," Dr al-Tamimi added.